B2DG Events - This Month

Topic Speaker Title Companysort icon Date Location
Overexpression of Mcl-1 confers resistance to BRAFV600E inhibitor therapy in melanoma Neel M. Fofaria PhD Candidate Texas Tech University Health Sciences Center, School of Pharmacy 03/31/2015 - 8:30am Sunnyvale
Active Investors and Exits in Venture Healthcare Jonathan Norris Managing Director of Healthcare Practice Silicon Valley Bank 03/10/2015 - 6:00pm Wilson
“Surgery Without a Trace” Cal Huntzinger Principal De3 MedTech, LLC 03/03/2015 - 8:30am Sunnyvale
Building a medical device management team for successful growth through acquisition William L. Mince . 03/24/2015 - 8:30am Sunnyvale

B2DG Events Search